Request Your Free Playbook Now:

"Rethinking GLP-1s: Smarter, More Sustainable Solutions"

This playbook explains how to reduce the GLP-1 cost burden by bringing real-world data together with predictive modeling and human-centric design.

No topic in healthcare is generating more attention—or more spend—than GLP-1s. These medications can be transformative, but most employer-funded GLP-1 strategies fall short because they misread both the data and the consumer. GLP-1s account for about 10.5% of total employer healthcare spend. Yet 73% of users discontinue treatment within a year, costing employers up to $10,000 per member in wasted spend.

The solution is to match the right members to the right treatments and offer effective alternatives to GLP-1s for everyone else. This playbook explains why employer denials of GLP-1s fail, and what smart benefit design looks like. You’ll learn how to:

• Build a step-up program to identify members who are most likely to benefit from GLP-1s.
• Offer wraparound plans that help members who are on GLP-1s stay on them.
• Create a structured, personalized, digitally enabled support program to help members maintain results and health benefits after discontinuing GLP-1s.

Offered Free by: HR Dive's Studio by Informa TechTarget and DarioHealth
See All Resources from: HR Dive's Studio by Informa TechTarget and DarioHealth